- Phare
- Validé par KD/KO
Anticorps Polyclonal de lapin anti-GLAST/EAAT1
GLAST/EAAT1 Polyclonal Antibody for WB, IHC, IF/ICC, FC (Intra), IP, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, rat, souris et plus (1)
Applications
WB, IHC, IF/ICC, FC (Intra), IP, CoIP, ELISA
Conjugaison
Non conjugué
N° de cat : 20785-1-AP
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en WB | cellules Neuro-2a, cellules C6, tissu cérébral de souris | 
| Résultats positifs en IP | tissu cérébral de souris | 
| Résultats positifs en IHC | tissu cérébral de souris,  tissu cérébral de rat il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0. | 
| Résultats positifs en IF/ICC | cellules Neuro-2a, | 
| Résultats positifs en FC (Intra) | cellules Neuro-2a | 
Dilution recommandée
| Application | Dilution | 
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 | 
| Immunoprécipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate | 
| Immunohistochimie (IHC) | IHC : 1:200-1:800 | 
| Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 | 
| Flow Cytometry (FC) (INTRA) | FC (INTRA) : 0.40 ug per 10^6 cells in a 100 µl suspension | 
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Applications publiées
| KD/KO | See 1 publications below | 
| WB | See 23 publications below | 
| IHC | See 2 publications below | 
| IF | See 11 publications below | 
| IP | See 1 publications below | 
| CoIP | See 1 publications below | 
Informations sur le produit
20785-1-AP cible GLAST/EAAT1 dans les applications de WB, IHC, IF/ICC, FC (Intra), IP, CoIP, ELISA et montre une réactivité avec des échantillons Humain, rat, souris
| Réactivité | Humain, rat, souris | 
| Réactivité citée | rat, Humain, souris, Vache | 
| Hôte / Isotype | Lapin / IgG | 
| Clonalité | Polyclonal | 
| Type | Anticorps | 
| Immunogène | GLAST/EAAT1 Protéine recombinante Ag14177 | 
| Nom complet | solute carrier family 1 (glial high affinity glutamate transporter), member 3 | 
| Masse moléculaire calculée | 542 aa, 60 kDa | 
| Poids moléculaire observé | 50-55 kDa, 90-100 kDa | 
| Numéro d’acquisition GenBank | BC037310 | 
| Symbole du gène | GLAST | 
| Identification du gène (NCBI) | 6507 | 
| Conjugaison | Non conjugué | 
| Forme | Liquide | 
| Méthode de purification | Purification par affinité contre l'antigène | 
| Tampon de stockage | PBS with 0.02% sodium azide and 50% glycerol | 
| Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. | 
Informations générales
SLC1A3, also known as EAAT-1 or GLAST, is a membrane-bound protein localized in glial cells and pre-synaptic glutamatergic nerve endings. It transports the excitatory neurotransmitters L-glutamate and D-aspartate, which is essential for terminating the postsynaptic acction of glutamate. Recently, a correlation between expression/function of glial EAAT-1 and tumor proliferation has been reported. The exceptionally rare expression of EAAT-1 in non-neoplastic choroid plexus (CP) compared to choroid plexus tumors (CPT) may distinguishes neoplastic from normal CP. There are a number of splicing variants of SLC1A3, like GLAST1a and GLAST1b, exist due to the exon skipping. It also undergo glycosylation. Variety of bands can be observed in the western blotting assay: 50-55 kDa represents the unglycosylated GLAST1a or GLAST1b, 65-70 kDa correspond to the glycosylated proteins, larger proteins between 90-130 kDa may be the multimers of SLC1A3. (11086157, 17471058, 12546822)
Protocole
| Product Specific Protocols | |
|---|---|
| WB protocol for GLAST/EAAT1 antibody 20785-1-AP | Download protocol | 
| IF protocol for GLAST/EAAT1 antibody 20785-1-AP | Download protocol | 
| IP protocol for GLAST/EAAT1 antibody 20785-1-AP | Download protocol | 
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols | 
Publications
| Species | Application | Title | 
|---|---|---|
| Nucleic Acids Res H2A.Z.1 crosstalk with H3K56-acetylation controls gliogenesis through the transcription of folate receptor. | ||
| Cell Rep SOX2 is essential for astrocyte maturation and its deletion leads to hyperactive behavior in mice | ||
| Cell Death Differ RNF20 controls astrocytic differentiation through epigenetic regulation of STAT3 in the developing brain. | ||
| J Neuroimmune Pharmacol Brain-Derived Exosomal CircRNAs in Plasma Serve as Diagnostic Biomarkers for Acute Ischemic Stroke | ||
| Biochem Pharmacol Regulatory roles of histamine receptor in astrocytic glutamate clearance under conditions of increased glucose variability | ||
| Neuropharmacology Ginsenoside Rb1 confers neuroprotection via promotion of glutamate transporters in a mouse model of Parkinson's disease. | 
Avis
The reviews below have been submitted by verified Proteintech customers who received an incentive for providing their feedback.
| FH Ryan (Verified Customer) (02-14-2018) | NaCit antigen retrieval ph = 6 
  | 
| FH Ryan (Verified Customer) (01-24-2018) | Antigen retrieval - 0.1M Tris-HCl ph9 
  | 








